source
- Novo Nordisk secures biotech partner for Parkinson's cell therapy as GSK signs hepatitis B drug deal in ChinaNovo Nordisk has found a biotech partner to advance its early‑stage Parkinson's disease cell therapy, giving the program a new development home. GSK disclosed a commercial agreement to sell its he…
- Endpoints Weekly highlights biotech company models, a quirky startup story, and earnings season updatesThe latest edition of Endpoints Weekly introduces a look at emerging biotech company structures, noting how new models are reshaping the industry. It also features a light‑hearted piece about a st…